Olexandr Vasylenko

1.4k total citations
14 papers, 1.2k citations indexed

About

Olexandr Vasylenko is a scholar working on Organic Chemistry, Toxicology and Molecular Biology. According to data from OpenAlex, Olexandr Vasylenko has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 2 papers in Toxicology and 1 paper in Molecular Biology. Recurrent topics in Olexandr Vasylenko's work include Synthesis and biological activity (14 papers), Synthesis of heterocyclic compounds (7 papers) and Synthesis and Biological Evaluation (5 papers). Olexandr Vasylenko is often cited by papers focused on Synthesis and biological activity (14 papers), Synthesis of heterocyclic compounds (7 papers) and Synthesis and Biological Evaluation (5 papers). Olexandr Vasylenko collaborates with scholars based in Ukraine, Poland and France. Olexandr Vasylenko's co-authors include Roman Lesyk, Borys Zimenkovsky, Dmytro Havrylyuk, Andrzej Gzella, Lucjusz Zaprutko, Dmytro Atamanyuk, Philippe Grellier, Danylo Kaminskyy, Craig W. Day and Donald F. Smee and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Letters.

In The Last Decade

Olexandr Vasylenko

14 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olexandr Vasylenko Ukraine 13 1.1k 245 113 80 72 14 1.2k
Andanappa K. Gadad India 18 1.1k 1.0× 318 1.3× 96 0.8× 39 0.5× 119 1.7× 38 1.3k
Borys Zimenkovsky Ukraine 21 1.8k 1.7× 409 1.7× 215 1.9× 142 1.8× 112 1.6× 56 2.1k
Mohamed M. Abdulla Egypt 21 1.1k 1.0× 245 1.0× 125 1.1× 72 0.9× 70 1.0× 47 1.2k
Rajesh A. Rane India 16 641 0.6× 247 1.0× 107 0.9× 53 0.7× 44 0.6× 36 846
Shijia Zhao China 13 869 0.8× 403 1.6× 80 0.7× 41 0.5× 46 0.6× 26 1.0k
Ashish Radadiya India 11 515 0.5× 188 0.8× 102 0.9× 32 0.4× 30 0.4× 20 715
Magda A.‐A. El‐Sayed Egypt 18 1.1k 1.1× 501 2.0× 205 1.8× 73 0.9× 109 1.5× 40 1.4k
Osama I. El‐Sabbagh Egypt 14 645 0.6× 168 0.7× 76 0.7× 34 0.4× 65 0.9× 27 753
Hanan H. Georgey Egypt 20 839 0.8× 349 1.4× 133 1.2× 32 0.4× 106 1.5× 47 1.0k

Countries citing papers authored by Olexandr Vasylenko

Since Specialization
Citations

This map shows the geographic impact of Olexandr Vasylenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olexandr Vasylenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olexandr Vasylenko more than expected).

Fields of papers citing papers by Olexandr Vasylenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olexandr Vasylenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olexandr Vasylenko. The network helps show where Olexandr Vasylenko may publish in the future.

Co-authorship network of co-authors of Olexandr Vasylenko

This figure shows the co-authorship network connecting the top 25 collaborators of Olexandr Vasylenko. A scholar is included among the top collaborators of Olexandr Vasylenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olexandr Vasylenko. Olexandr Vasylenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kaminskyy, Danylo, et al.. (2014). Isothiocoumarin-3-carboxylic acid derivatives: Synthesis, anticancer and antitrypanosomal activity evaluation. European Journal of Medicinal Chemistry. 75. 57–66. 35 indexed citations
2.
Havrylyuk, Dmytro, Borys Zimenkovsky, Olexandr Vasylenko, et al.. (2013). Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones. European Journal of Medicinal Chemistry. 66. 228–237. 88 indexed citations
3.
4.
Havrylyuk, Dmytro, Borys Zimenkovsky, Olexandr Vasylenko, & Roman Lesyk. (2013). Synthesis and Anticancer and Antiviral Activities of New 2‐Pyrazoline‐Substituted 4‐Thiazolidinones. Journal of Heterocyclic Chemistry. 50(S1). 50 indexed citations
5.
Atamanyuk, Dmytro, et al.. (2012). Synthesis and antitrypanosomal activity of new 6,6,7-trisubstituted thiopyrano[2,3-d][1,3]thiazoles. Bioorganic & Medicinal Chemistry Letters. 22(23). 7071–7074. 53 indexed citations
6.
Havrylyuk, Dmytro, Borys Zimenkovsky, Olexandr Vasylenko, Andrzej Gzella, & Roman Lesyk. (2012). Synthesis of New 4-Thiazolidinone-, Pyrazoline-, and Isatin-Based Conjugates with Promising Antitumor Activity. Journal of Medicinal Chemistry. 55(20). 8630–8641. 218 indexed citations
7.
Havrylyuk, Dmytro, et al.. (2011). Synthesis and Anticancer Activity of Isatin‐Based Pyrazolines and Thiazolidines Conjugates. Archiv der Pharmazie. 344(8). 514–522. 93 indexed citations
8.
Lesyk, Roman, Danylo Kaminskyy, Olexandr Vasylenko, Dmytro Atamanyuk, & Andrzej Gzella. (2011). Isorhodanine and Thiorhodanine Motifs in the Synthesis of Fused Thiopyrano[2,3-d][1,3]thiazoles. Synlett. 2011(10). 1385–1388. 24 indexed citations
9.
Kaminskyy, Danylo, et al.. (2011). An efficient method for the transformation of 5-ylidenerhodanines into 2,3,5-trisubstituted-4-thiazolidinones. Tetrahedron Letters. 53(5). 557–559. 23 indexed citations
10.
Kaminskyy, Danylo, Barbara Bednarczyk–Cwynar, Olexandr Vasylenko, et al.. (2011). Synthesis of new potential anticancer agents based on 4-thiazolidinone and oleanane scaffolds. Medicinal Chemistry Research. 21(11). 3568–3580. 59 indexed citations
11.
Havrylyuk, Dmytro, et al.. (2010). Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. European Journal of Medicinal Chemistry. 45(11). 5012–5021. 210 indexed citations
12.
Atamanyuk, Dmytro, Ewa Szymańska, Katarzyna Kieć‐Kononowicz, et al.. (2010). Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity. Bioorganic & Medicinal Chemistry. 18(14). 5090–5102. 90 indexed citations
13.
Havrylyuk, Dmytro, Borys Zimenkovsky, Olexandr Vasylenko, et al.. (2009). ChemInform Abstract: Synthesis of Novel Thiazolone‐Based Compounds Containing Pyrazoline Moiety and Evaluation of Their Anticancer Activity.. ChemInform. 40(31). 1 indexed citations
14.
Havrylyuk, Dmytro, Borys Zimenkovsky, Olexandr Vasylenko, et al.. (2008). Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. European Journal of Medicinal Chemistry. 44(4). 1396–1404. 259 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andanappa K. Gadad Breakdown of academic impact, for papers by Borys Zimenkovsky Breakdown of academic impact, for papers by Mohamed M. Abdulla Breakdown of academic impact, for papers by Rajesh A. Rane Breakdown of academic impact, for papers by Shijia Zhao Breakdown of academic impact, for papers by Ashish Radadiya Breakdown of academic impact, for papers by Magda A.‐A. El‐Sayed Breakdown of academic impact, for papers by Osama I. El‐Sabbagh Breakdown of academic impact, for papers by Hanan H. Georgey
Rankless by CCL
2026